Cabot (NYSE:CBT) Issues Earnings Results, Misses Estimates By $0.01 EPS

Cabot (NYSE:CBT) posted its quarterly earnings data on Monday. The specialty chemicals company reported $1.80 EPS for the quarter, missing analysts’ consensus estimates of $1.81 by ($0.01), Briefing.com reports. Cabot had a return on equity of 26.99% and a net margin of 12.05%. The firm had revenue of $1 billion during the quarter, compared to analyst estimates of $1.01 billion. During the same period in the prior year, the business posted $1.65 EPS. The company’s revenue for the quarter was up 3.7% on a year-over-year basis. Cabot updated its FY 2025 guidance to 7.400-7.800 EPS and its FY25 guidance to $7.40-7.80 EPS.

Cabot Stock Up 7.5 %

Shares of Cabot stock traded up $8.16 during midday trading on Wednesday, reaching $117.02. 765,067 shares of the company’s stock traded hands, compared to its average volume of 339,948. The company has a market cap of $6.42 billion, a price-to-earnings ratio of 17.36, a price-to-earnings-growth ratio of 0.91 and a beta of 1.20. The company’s 50 day simple moving average is $108.41 and its 200 day simple moving average is $101.13. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.45 and a current ratio of 2.22. Cabot has a 52 week low of $68.11 and a 52 week high of $117.37.

Insider Activity

In related news, CEO Sean D. Keohane sold 25,617 shares of Cabot stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total value of $2,601,406.35. Following the transaction, the chief executive officer now owns 331,174 shares in the company, valued at $33,630,719.70. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. In related news, CEO Sean D. Keohane sold 25,617 shares of Cabot stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total value of $2,601,406.35. Following the transaction, the chief executive officer now owns 331,174 shares in the company, valued at $33,630,719.70. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Erica Mclaughlin sold 16,390 shares of Cabot stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $104.24, for a total transaction of $1,708,493.60. Following the completion of the transaction, the chief financial officer now owns 59,814 shares in the company, valued at $6,235,011.36. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 48,665 shares of company stock worth $4,986,299. 3.07% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

CBT has been the subject of a number of research reports. Mizuho lifted their target price on shares of Cabot from $103.00 to $122.00 and gave the company an “outperform” rating in a research note on Tuesday. JPMorgan Chase & Co. lifted their target price on shares of Cabot from $95.00 to $105.00 and gave the company a “neutral” rating in a research note on Wednesday, August 7th. Finally, UBS Group decreased their target price on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating for the company in a research note on Tuesday, August 6th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $105.00.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.